Seattle foundations behind new malaria vaccine trial

| November 11, 2008

Two Seattle-based foundations are behind a large malaria vaccine trial being launched in Africa next month.

The trial will enrol 16,000 children to test a promising vaccine that in earlier trials proved to be at least partially effective.

The trial has been organised by PATH, a Seattle-based foundation that specializes in global health, in cooperation with the British drug company GlaxoSmithKline, and is being funded with a grant from Seattle’s Bill & Melinda Gates Foundation.

To learn more:

 

  • Read the Associated Press report about the upcoming trial.
  • Visit the PATH Malaria Vaccine Initiative’s website.
  • Visit the Gates Foundation web page on malaria
  • View the BBC’s 22-minute documentary on malaria vaccine research available on the PATH Malaria Vaccine Initiatives website.
Share

Tags: , , ,

Category: Global Health, Infections

Comments (0)

Trackback URL | Comments RSS Feed

There are no comments yet. Why not be the first to speak your mind.

Comments are closed.